FDA delays deadline for electric shock device ban

The Food and Drug Administration has quietly moved the enforcement date for the ban on certain electric shock devices to a later point in time. The agency did not issue a high‑profile announcement, but the adjustment gives manufacturers additional time to meet the new requirements.

The original deadline had been set earlier this year, prompting industry groups to prepare for compliance. By extending the timeline, the FDA aims to reduce disruption while still pursuing its safety objectives.

Stakeholders, including healthcare providers and device makers, will need to revise their rollout plans in light of the new schedule. The change was noted among other health news items in a recent briefing, underscoring the agency's ongoing regulatory activity.